Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

In 2010, Purdue Pharma replaced the original version of OxyContin, an extended-release oxycodone pill, with a reformulated product that was much harder to crush for snorting or injection. The reformulation of OxyContin was instead associated with an increase in deaths involving illicit opioids and, ultimately, an overall increase in fatal drug overdoses. Researchers ... found that death rates rose fastest in states where reformulation would have had the biggest impact. A new study by RAND Corporation senior economist David Powell extends those findings by showing that the reformulation of OxyContin also was associated with rising suicides among children and teenagers. The root cause of such perverse effects was the substitution that occurred after the old version of OxyContin was retired. Nonmedical users turned to black-market alternatives that were more dangerous because their potency was highly variable and unpredictable–a hazard that was compounded by the emergence of illicit fentanyl as a heroin booster and substitute. The fallout from the reformulation of OxyContin is one example of a broader tendency: Interventions aimed at reducing the harm caused by substance abuse frequently have the opposite effect. Based on interstate differences in nonmedical use of OxyContin prior to 2010, Powell estimates that "the reformulation of OxyContin can explain 49% of the rise in child suicides."

Note: More than 107,000 people in the United States died due to opioid overdoses in 2021. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

In 2009, Laura Esserman, a breast cancer surgeon and oncology specialist in San Francisco, co-published an article in the Journal of the American Medical Association (JAMA) suggesting that it was time to rethink routine screening for breast and prostate cancer. The current approach, she wrote, wasn't reducing aggressive or late-stage disease as much as had been hoped. Instead, it was leading to overdiagnosis. Ductal carcinoma in situ, a condition sometimes called non-invasive or stage-zero breast cancer, is a very early finding of disease in the cells that line the milk ducts of the breast. For decades, the diagnosis of DCIS has routinely led to surgery–a mastectomy or a lumpectomy (a partial breast resection) that's often combined with radiation treatment. The issue? In a study of 100,000 women who were followed for two decades, patients who'd been diagnosed with and treated for DCIS ultimately had about the same chance of dying from breast cancer as those in the general population. In August, a meta-analysis of 18 randomized clinical trials involving 2.1 million people, published in JAMA Internal Medicine, concluded that "current evidence does not substantiate the claim" that common cancer screens (mammography, colonoscopy, prostate-specific antigen (PSA) testing, etc) save lives. "In our exuberance to find these cancers, we have basically turned a lot of healthy people who are not destined to die from the cancers into patients," says Ade Adamson, a cancer screening expert.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Procter & Gamble (PG.N), Walgreens (WBA.O) and Johnson & Johnson's (JNJ.N) former consumer business are among several companies accused in lawsuits of deceiving consumers about cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel declared ineffective. Proposed class actions were filed on Wednesday and Thursday, after the panel reviewed several studies and concluded this week that the ingredient phenylephrine marketed as a decongestant was essentially no better than a placebo. According to an agency presentation, about 242 million products with phenylephrine were sold in the United States last year, generating $1.76 billion of sales and accounting for about four-fifths of the market for oral decongestants. The first lawsuit appeared to have been filed in Pensacola, Florida, federal court. It said Johnson & Johnson Consumer and Procter & Gamble should have known by 2018 that their marketing claims about products with phenylephrine were "false and deceptive." That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine's effectiveness could no longer be relied upon, the complaint said. The plaintiff Steve Audelo, a Florida resident, said he bought Johnson & Johnson's Sudafed PE and Benadryl Allergy Plus, and Procter & Gamble's Vicks NyQuil, based on the companies' claims that the products worked.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and corporate corruption from reliable major media sources.

Widespread loneliness in the U.S. poses health risks as deadly as smoking up to 15 cigarettes daily, costing the health industry billions of dollars annually, the U.S. surgeon general said. About half of U.S. adults say they've experienced loneliness, Dr. Vivek Murthy said in an 81-page report. "Loneliness is ... a feeling the body sends us when something we need for survival is missing," Murthy [said]. "Millions of people in America are struggling. That's why I issued this advisory." Research shows that Americans, who have become less engaged with worship houses, community organizations and even their own family members in recent decades, have steadily reported an increase in feelings of loneliness. People culled their friend groups during the coronavirus pandemic. Americans spent about 20 minutes a day in person with friends in 2020, down from 60 minutes daily nearly two decades earlier. The loneliness epidemic is hitting young people, ages 15 to 24, especially hard. The age group reported a 70% drop in time spent with friends during the same period. Loneliness increases the risk of premature death by nearly 30%, with the report revealing that those with poor social relationships also had a greater risk of stroke and heart disease. Isolation also elevates a person's likelihood for experiencing depression, anxiety and dementia. People who used social media for two hours or more daily were more than twice as likely to report feeling socially isolated than those who were on such apps for less than 30 minutes a day.

Note: Listen to an inspiring interview with U.S. Surgeon General Dr. Vivek Murthy, where he envisions a new 'social' infrastructure for humanity that consists of programs, policies, and structures that foster healthy relationships and bring healing to the mental health crisis. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

A federal appeals court in Philadelphia rejected Johnson & Johnson â€˜s use of chapter 11 bankruptcy to freeze roughly 40,000 lawsuits linking its talc products to cancer, blunting a strategy the consumer health giant and a handful of other profitable companies have used to sidestep jury trials. The Third U.S. Circuit Court of Appeals on Monday dismissed the chapter 11 case of J&J subsidiary LTL Management LLC, which the company created in 2021 to move the talc injury lawsuits to bankruptcy court and freeze them in place. J&J is now exposed once again to talc-related cancer claims that have cost the company's consumer business $4.5 billion in recent years and are expected to continue for decades. J&J tried to stanch those costs through an emerging corporate restructuring strategy that offered J&J and other companies the protections of bankruptcy, despite their solvent balance sheets and solid credit ratings, and put a total of more than 250,000 injury lawsuits against the businesses on hold. Monday's decision marks the first time a federal appeals court has disapproved of the bankruptcy strategy, known in legal circles as the Texas Two-Step. The court's decision could mark tougher scrutiny of the legal tactic, which would make it harder for big companies to move past potentially costly and time-consuming personal-injury litigation. Bankruptcy allows companies swamped by lawsuits to drive settlements of legal liabilities through a chapter 11 plan and stop litigation from advancing in the civil justice system.

Note: Johnson & Johnson knew that its products caused cancer and lied to the public about it for decades. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

Music, it turns out, is medicine for the mind. [A 2021 study] set out to see what happens in the brain when a person with mild cognitive impairment or early Alzheimer's disease listens to their favorite playlist for an hour every day. The 14 participants had brain scans and took neuropsychological tests that involved memory exercises. At the end of the trial the participants showed a small but statistically significant improvement in memory – something that is extremely unusual. New connections had formed between different regions of the brain ... that actually changed brain plasticity and also improved function in relaying information. Thaut says the research shows that while music is in no way a cure for Alzheimers, it can provide a "cognitive boost." That's why a person with memory impairment may not recall their daughter's name but may remember all the lyrics to her favorite lullaby. "It's pulling from emotions, it's pulling from feelings, it's pulling from interpersonal associations, it's pulling from a date or time or period of one's life – historical things," [Concetta] Tomaino says. Music serves as a clue, coaxing the brain to fill in the blanks. "It is painful to watch your beloved slip away inch by inch," [Carol Rosenstein] says. "And if it weren't for the music, I wouldn't be sitting here today. As a caregiver and first responder, I can tell you, I would have never survived the journey."

Note: Watch a deeply moving video of Henry, a 94-year old man with dementia, experience music for the first time in years.

Public-health experts are sounding the alarm about a new Omicron variant dubbed XBB. It isn't clear that XBB is any more lethal than other variants, but its mutations enable it to evade antibodies from prior infection and vaccines. Growing evidence also suggests that repeated vaccinations may make people more susceptible to XBB and could be fueling the virus's rapid evolution. Prior to Omicron's emergence in November 2021, there were only four variants of concern: Alpha, Beta, Delta and Gamma. Only Alpha and Delta caused surges of infections globally. But Omicron has begotten numerous descendents. "Such rapid and simultaneous emergence of multiple variants with enormous growth advantages is unprecedented," a Dec. 19 study in the journal Nature notes. The same study posits that immune imprinting may be contributing to the viral evolution. Vaccines do a good job of training the immune system to remember and knock out the original Wuhan variant. But when new and markedly different strains come along, the immune system responds less effectively. A Cleveland Clinic study that tracked its healthcare workers found that ... workers who had received more [vaccine] doses were at higher risk of getting sick. Those who received three more doses were 3.4 times as likely to get infected as the unvaccinated, while those who received two were only 2.6 times as likely. "This is not the only study to find a possible association with more prior vaccine doses and higher risk of COVID-19," the authors noted.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

How accurate are the coronavirus tests used in the U.S.? Months into the outbreak, no one really knows. When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus. That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy. There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths. Cases in nearly half of U.S. states are rising. Most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available. Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House. The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus. Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

When pharmaceutical company Moderna issued a press release about the promising results of its Phase I clinical trial for a coronavirus vaccine, the media and the markets went wild. Upon examining Moderna's non-peer reviewed press release, the actual data on the vaccine's success is ... flimsy. Of the 45 patients who received the vaccine, the data on "neutralising antibody data are available only for the first four participants in each of the 25-microgram and 100-microgram dose level cohorts." In other words, that means that when it comes to finding out whether the vaccine elicits an antibody response that could potentially fight the coronavirus, they only had data on eight patients. That's not enough to do any type of statistical analysis and it also brings into question the status of the other 37 patients who also received the vaccine. Moderna's messenger RNA vaccine ... uses a sequence of genetic RNA material produced in a lab that, when injected into your body, must invade your cells and hijack your cells' protein-making machinery called ribosomes to produce the viral components that subsequently train your immune system to fight the virus. There are unique and unknown risks to messenger RNA vaccines, including the possibility that they generate strong type I interferon responses that could lead to inflammation and autoimmune conditions. Messenger RNA vaccines have never before been brought to market for human patients.

Note: To learn about the serious risks and dangers of these mRNA vaccines, don't miss the vitally important information given by Christiane Northrup, MD, in the first five minutes of this highly revealing video. Reader's Digest named Dr. Northrup one of "The 100 Most Trusted People in America." Dr. Northrup's work has been featured on The Oprah Winfrey Show, the Today Show, NBC Nightly News, Good Morning America, 20/20, and The Dr. Oz Show. For more, see concise summaries of revealing news articles on the coronavirus and vaccines from major media sources.

The US [provided a] $3.7 million grant to the Wuhan-based laboratory carrying out research on virus derived from bat caves. The Wuhan Institute of Virology (WIV) was conducting the coronavirus experiments on mammals, with funds received from the United States National Institute of Health. The NIH has been listed as a partner by the Wuhan Institute of Virology. Other American institutes that have partnered with the research lab, include: University of Alabama, University of North Texas Eco Health Alliance [and] Harvard University. WIV ... has more than 1,500 strains of deadly viruses stored and specialises in research of 'the most dangerous pathogens', in particular the viruses carried by bats. The project released its first research in November 2017 ... titled 'Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.' Hitting out at the US government, US Congressman Matt Gaetz said: "I'm disgusted to learn that for years the US government has been funding dangerous and cruel animal experiments at the Wuhan Institute, which may have contributed to the global spread of coronavirus." Conspiracy theories have been hinting at the possibility of the virus being developed in the WIV. Last week, Cao Bin, a doctor at the Wuhan Jinyintan Hospital ... revealed that out of the first 41 cases found positive for coronavirus, 13 had no contact with the wildlife market, raising the doubts that the virus was in fact lab originated. 'It seems clear that the seafood market is not the only origin of the virus,' he said.

Note: Newsweek reported that in 2017, Anthony Fauci predicted a "surprise outbreak" during Trump's presidency. Respected author Peter Breggin, M.D., has uncovered more on how the U.S. and China collaborated to transform an animal coronavirus into one that can attack humans. Don't miss his excellent essay with a link direct to the study, which was published in the prestigious British journal Nature. Why was an FDA official involved and why was NIH funding a project that enabled the Chinese to develop a military weapon or to accidentally or purposely cause an epidemic?

A series of missteps at the nation's top public health agency caused a critical shortage of reliable laboratory tests for the coronavirus. President Donald Trump assured Americans early this month that the COVID-19 test developed by the Centers for Disease Control and Prevention is "perfect" and that "anyone who wants a test can get a test." But more than two months after the first U.S. case of the new disease was confirmed, many people still cannot get tested. Four primary issues ... hampered the national response — the early decision not to use the test adopted by the World Health Organization, flaws with the more complex test developed by the CDC, government guidelines restricting who could be tested and delays in engaging the private sector to ramp up testing capacity. By mid-February, only about a half-dozen state and local public health labs had reliable tests. But still, CDC Director Dr. Robert Redfield continued to insist his agency had developed "a very accurate test." "We found that, in some of the states, it didn't work," Redfield said earlier this month. As more sick people sought to be tested, many states were forced to limit access because of the flawed CDC test. Accounts began to emerge ... of people with all the symptoms of COVID-19 who either couldn't get tested or had test results delayed. On Feb. 29, only 472 patients had been tested nationwide, with just 22 cases confirmed, according to CDC data. By comparison, South Korea ... mobilized to test more than 20,000 people a day.

Note: Explore a ZeroHedge article titled "Whistleblower: How CDC Is Manipulating The COVID-19 Death-Toll." A BMJ article titled "Covid-19: four fifths of cases are asymptomatic, China figures indicate" quotes one epidemiologist as asking "What the hell are we locking down for?" For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus pandemic from reliable major media sources.

A whistleblower who works in Project Nightingale, the secret transfer of the personal medical data of up to 50 million Americans from one of the largest healthcare providers in the US to Google, has expressed anger to the Guardian that patients are being kept in the dark about the massive deal. The anonymous whistleblower has posted a video on the social media platform Daily Motion that contains a document dump of hundreds of images of confidential files relating to Project Nightingale. The secret scheme ... involves the transfer to Google of healthcare data held by Ascension, the second-largest healthcare provider in the US. The data is being transferred with full personal details including name and medical history and can be accessed by Google staff. Unlike other similar efforts it has not been made anonymous through a process of ... de-identification. The disclosed documents include highly confidential outlines of Project Nightingale, laying out the four stages or “pillars” of the secret project. By the time the transfer is completed next March, it will have passed the personal data of 50 million or more patients in 21 states to Google, with 10 million or so files already having moved across – with no warning having been given to patients or doctors. Google has entered into similar partnerships on a much smaller scale with clients such as the Colorado Center for Personalized Medicine. But in that case all the data handed over to the search giant was encrypted, with keys being held only on the medical side.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.

Federal officials on Tuesday ended a moratorium imposed three years ago on funding research that alters germs to make them more lethal. Such work can now proceed, said Dr. Francis S. Collins, the head of the National Institutes of Health, but only if a scientific panel decides that the benefits justify the risks. Some scientists are eager to pursue these studies because they may show, for example, how a bird flu could mutate to more easily infect humans, or could yield clues to making a better vaccine. Critics say these researchers risk creating a monster germ that could escape the lab and seed a pandemic. In October 2014, all federal funding was halted on efforts to make three viruses more dangerous: the flu virus, and those causing Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). But the new regulations apply to any pathogen that could potentially cause a pandemic. There has been a long, fierce debate about projects — known as “gain of function” research — intended to make pathogens more deadly or more transmissible. Tensions rose in 2014 after the Centers for Disease Control and Prevention accidentally exposed lab workers to anthrax and shipped a deadly flu virus to a laboratory that had asked for a benign strain. That year, the N.I.H. also found vials of smallpox in a freezer that had been forgotten for 50 years. When the moratorium was imposed, it effectively halted 21 projects. In the three years since, the N.I.H. created exceptions that funded ten of those projects.

Note: This article was written three years before the coronavirus hit. Could the lifting of this ban and later U.S. funding of the highest level virology lab in Wuhan have played a role in the pandemic? For more along these lines, see concise summaries of deeply revealing news articles on science corruption and health from reliable major media sources.

In the 1960s, the sugar industry funded research that downplayed the risks of sugar and highlighted the hazards of fat, according to a newly published article in JAMA Internal Medicine. The article draws on internal documents to show that an industry group called the Sugar Research Foundation wanted to "refute" concerns about sugar's possible role in heart disease. The SRF then sponsored research by Harvard scientists that did just that. The result was published in the New England Journal of Medicine in 1967, with no disclosure of the sugar industry funding. There's no evidence that the SRF directly edited the manuscript published by the Harvard scientists in 1967, but there is "circumstantial" evidence that the interests of the sugar lobby shaped the conclusions of the review, the researchers say. The documents in question are five decades old, but the larger issue is of the moment, as Marion Nestle notes in a commentary in the same issue of JAMA Internal Medicine: "Is it really true that food companies deliberately set out to manipulate research in their favor? Yes, it is, and the practice continues. In 2015, the New York Times obtained emails revealing Coca-Cola's cozy relationships with sponsored researchers who were conducting studies aimed at minimizing the effects of sugary drinks on obesity. More recently, the Associated Press obtained emails showing how a candy trade association funded and influenced studies to show that children who eat sweets have healthier body weights than those who do not."

Note: Read more on the sugar industry's manipulation of science. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.

The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article ... in a leading medical journal. The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals. The article cited one draft of a Vioxx research study that was still in want of a big-name researcher, identifying the lead writer only as "External author?" Vioxx was a best-selling drug before Merck pulled it from the market in 2004 over evidence linking it to heart attacks. Last fall the company agreed to a $4.85 billion settlement to resolve tens of thousands of lawsuits. The lead author of Wednesday's article, Dr. Joseph S. Ross ... said a close look at the Merck documents raised broad questions about the validity of much of the drug industry's published research, because the ghostwriting practice appears to be widespread. "It almost calls into question all legitimate research that's been conducted by the pharmaceutical industry with the academic physician," Dr. Ross said, whose article ... was published Wednesday in JAMA, the journal of the American Medical Association. Although the role of pharmaceutical companies in influencing medical journal articles has been questioned before, the Merck documents provided the most comprehensive look at the magnitude of the practice.

Note: Vioxx may have been responsible for 500,000 premature deaths. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters "can be done once, or maybe twice, but it's not something that we can think should be repeated constantly," Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. "We need to think about how we can transition from the current pandemic setting to a more endemic setting."

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

An Upstate New York hospital announced that it will stop delivering babies this month after several staffers in the maternity department resigned over the hospital system's coronavirus vaccine mandate. At least six unvaccinated maternity staffers at Lewis County General Hospital have resigned in recent days, and seven others remain undecided on whether to get vaccinated, Gerald Cayer, chief executive officer of the Lewis County Health System, said. The staff shortage will result in the hospital being "unable to safely staff" the maternity department beginning Sept. 25, he said. Cayer said 165 hospital staffers, about 27 percent of the workforce, remain unvaccinated. Seventy-three percent of those unvaccinated staffers provide clinical services at the hospital. As hospitals have implemented vaccination mandates, some staffers have chosen to resign or be fired instead of getting the shots. More than 150 health-care workers who did not comply with the vaccine mandate at Houston Methodist – one of the first health systems to require the coronavirus shots – resigned or were fired in June. A lawsuit brought by one of those employees – which alleged that the policy was forcing staffers to be "guinea pigs" for vaccines that had not gone through the full Food and Drug Administration approval process – was dismissed by a federal judge. Other instances of pushback have popped up in recent months. In Winchester, Va., some unvaccinated nurses are choosing to be fired in protest of their hospital system's mandate.

Note: One year ago these health workers were heroes for risking their lives on the front line with COVID patients. Now they are being ridiculed for not wanting to be vaccinated. Listen to their own moving words in this important video. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

When West Virginia declared a state of emergency to arrest the coronavirus, the social network that aids the homeless froze along with everything else. Ordered to shelter in place, people without shelter died at an alarming rate. In a bad year here ... two to four of the unhoused die. Over the past year, they have tallied 22 deaths, a sevenfold increase. Only two of the deaths are suspected to be from COVID-19. But all occurred during the collapse of the safety net that in normal times addresses the complex mix of ­afflictions–trauma, medical conditions, addiction–that accompany homelessness, and worsened during the profound isolation of the pandemic. What happened in [West Virginia] is happening across the country. Even before the pandemic lockdowns that fell hardest on low-income Americans –– and stand to push more people out of their homes –– the Department of Housing and Urban Development reported U.S. homelessness at 580,466 people, up 7% from a year earlier. Deaths are rising even faster. In San Francisco, the department of public health says deaths tripled over the past year in an unhoused population of 8,035. In Los Angeles, home to a vast homeless population tallied at 41,290, deaths increased by 32%. Homeless deaths in Washington, D.C., soared by 54%. In New York City, the Coalition for the Homeless reported a death rate up 75%. And over the past year, they died ... at a rate many times higher than the rate of deaths from the virus.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and income inequality from reliable major media sources.

Across the pharmaceutical and medical industries, senior executives and board members are making millions of dollars after announcing positive developments, including support from the government, in their efforts to fight Covid-19. After such announcements, insiders from at least 11 companies – most of them smaller firms whose fortunes often hinge on the success or failure of a single drug – have sold shares worth well over $1 billion since March, according to figures compiled for The New York Times. The sudden windfalls highlight the powerful financial incentives for company officials to generate positive headlines in the race for coronavirus vaccines and treatments, even if the drugs might never pan out. Some officials at the Department of Health and Human Services have grown concerned about whether companies are trying to inflate their stock prices by exaggerating their roles in Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19. In some cases, company insiders ... appear to be pouncing on opportunities to cash out while their stock prices are sky high. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. "It is inappropriate for drug company executives to cash in on a crisis," said Ben Wakana, executive director of Patients for Affordable Drugs. "Every day, Americans wake up and make sacrifices during this pandemic. Drug companies see this as a payday."

Note: For more along these lines, see concise summaries of deeply revealing news articles on big Pharma corruption and the coronavirus from reliable major media sources.

A former head of MI6 has said he believes the coronavirus pandemic "started as an accident" when the virus escaped from a laboratory in China. Sir Richard Dearlove ... pointed to a scientific paper published this week by a Norwegian-British research team who claim to have discovered clues within Covid-19's genetic sequence suggesting key elements were "inserted" and may not have evolved naturally. In their paper, the scientists claim to have identified "inserted sections placed on the SARS-CoV-2 Spike surface" that explain how the virus binds itself to human cells. "The SARS-CoV-2 spike is significantly different from any other Sars that we have studied," the paper says. Two laboratories in Wuhan studying bat coronaviruses – the Wuhan Institute of Virology and the Wuhan Centre for Disease Control – have been suggested as the possible true sources of the outbreak. Sir Richard suggested scientists may have been conducting secret gene-splicing experiments on bat coronaviruses when Covid-19 somehow escaped. Sir Richard said he did not believe the Chinese had released the virus deliberately, but accused Beijing of subsequently covering up the scale of its spread. Last month, the US Secretary of State, Mike Pompeo, claimed there was "enormous evidence" that the coronavirus outbreak originated in a Chinese laboratory, but did not provide any proof. However, the US National Intelligence Director's office later said it had determined that Covid-19 "was not manmade".

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.